Alternating radiotherapy and chemotherapy in 173 consecutive patients with limited small cell lung carcinoma
β Scribed by R. Arriagada; T. Le Chevalier; P. Ruffie; P. Baldeyrou; H. De Cremoux; M. Martin; P. Chomy; M.L. Cerrina; B. Pellae-Cosset; M. Tarayre; H. Sancho-Garnier
- Publisher
- Elsevier Science
- Year
- 1990
- Tongue
- English
- Weight
- 415 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND Neurologic complications are an important cause of morbidity and possibly also mortality in patients with small cell lung carcinoma (SCLC). The current study was undertaken to prospectively investigate survival and the frequency of neurologic disorders in patients with SC
From June 1979 through April 1982, we treated 35 patients with limited small cell carcinoma on an intensive chemo-radio-immunotherapy regimen, consisting of induction with cyclophosphamide, doxorubicin, and vincristine, alternately cycled with VP-16 and cisplatin. Patients were stratified by perform
## BACKGROUND. Although thoracic radiotherapy is considered to be useful for the treatment of patients with small cell lung carcinoma (SCLC), its optimal administration schedule is still controversial. ## METHODS. In a multicenter clinical trial, 164 patients with limited SCLC (of whom 156 were e